Jonathan Todd Garland Cytek Biosciences, Inc. (CTKB) insider trading activity

Jonathan Todd Garland is Chief Commercial Officer of Cytek Biosciences, Inc.. Currently has a direct ownership of 8,763 shares of CTKB, which is worth approximately $44,778. The most recent transaction as insider was on Aug 18, 2023, when has been sold 1,836 shares (Common Stock) at a price of $8.46 per share, resulting in proceeds of $15,532. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.76K

0% 3M change

0% 12M change

Total Value Held $44,778

Jonathan Todd Garland Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 18 2023	SELL Payment of exercise price or tax liability	$15,532 $8.46 p/Share	1,836 Reduced 17.32%	8,763 Common Stock
Aug 18 2023	BUY Exercise of conversion of derivative security	-	4,712 Added 32.38%	9,839 Common Stock
May 18 2023	SELL Payment of exercise price or tax liability	$25,134 $6.69 p/Share	3,757 Reduced 38.96%	5,887 Common Stock
May 18 2023	BUY Exercise of conversion of derivative security	-	9,644 Added 59.35%	6,604 Common Stock

Also insider at

NSTG

NanoString Technologies Inc Healthcare

Chief Commercial Officer

JTG